期刊
DISEASE MARKERS
卷 2015, 期 -, 页码 -出版社
HINDAWI LTD
DOI: 10.1155/2015/520590
关键词
-
类别
资金
- Mayo Clinic NIH relief program [CA 190272 RELIEF]
- Mayo Center for Individualized Medicine lung cancer group fund
- Mayo Clinic Cancer Center Fraternal Order of Eagles Cancer Research Fund
Lung cancer is one of the most common types of human malignancies and the leading cause of cancer-related death. Patients with surgically resectable early stage lung cancer are more likely curable, but currently only a small population of patients can be diagnosed at such a stage, partly due to our incomplete understanding of the biology of lung cancer and the lack of diagnostic and prognostic biomarkers. Recent studies have shown that NOTCH1 is a critical regulator of human carcinogenesis and has been implicated in multiple steps of cancer development and progression. Herein, we review recent findings about the role of NOTCH1 in lung cancer and discuss its potential usefulness as both a therapeutic target and a biomarker for lung cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据